{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:56:58Z","timestamp":1770739018816,"version":"3.49.0"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,8,1]]},"DOI":"10.2169\/internalmedicine.4337-19","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T22:12:18Z","timestamp":1588198338000},"page":"1873-1877","source":"Crossref","is-referenced-by-count":3,"title":["Coronary Spastic Angina Induced by Adrenal Insufficiency"],"prefix":"10.2169","volume":"59","author":[{"given":"Yuki","family":"Otsuka","sequence":"first","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ko","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kou","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101: 364-389, 2016."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Choudhury S, Lightman S, Meeran K. Improving glucocorticoid replacement profiles in adrenal insufficiency. Clin Endocrinol (Oxf) 91: 367-371, 2019.","DOI":"10.1111\/cen.13999"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bensing S, Brandt L, Tabaroj F, et al. Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin Endocrinol (Oxf) 69: 697-704, 2008.","DOI":"10.1111\/j.1365-2265.2008.03340.x"},{"key":"4","unstructured":"4. Bergthorsdottir R, Leonsson-Zachrisson M, Od\u00e9n A, Johannsson G. Premature mortality in patients with Addison&apos;s disease: a population-based study. J Clin Endocrinol Metab 91: 4849-4853, 2006."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Amin A, Sam AH, Meeran K. Glucocorticoid replacement. BMJ 349: g4843, 2014.","DOI":"10.1136\/bmj.g4843"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Oprea A, Bonnet NCG, Poll\u00e9 O, Lysy PA. Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency. Ther Adv Endocrinol Metab 10: 2042018818821294, 2019.","DOI":"10.1177\/2042018818821294"},{"key":"7","unstructured":"7. Rahvar AH, Haas CS, Danneberg S, Harbeck B. Increased cardiovascular risk in patients with adrenal insufficiency: a short review. Biomed Res Int 2017: 3691913, 2017."},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Mastorakos G, Paltoglou G, Greene M, et al. Inappropriately normal plasma ACTH and cortisol concentrations in the face of increased circulating interleukin-6 concentration in exercise in patients with sarcoidosis. Stress 16: 202-210, 2013.","DOI":"10.3109\/10253890.2012.715221"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Papanicolaou DA, Tsigos C, Oldfield EH, Chrousos GP. Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency? J Clin Endocrinol Metab 81: 2303-2306, 1996.","DOI":"10.1210\/jcem.81.6.8964868"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tsigos C, Kyrou I, Chrousos GP, Papanicolaou DA. Prolonged suppression of corticosteroid-binding globulin by recombinant human interleukin-6 in man. J Clin Endocrinol Metab 83: 3379, 1998.","DOI":"10.1210\/jcem.83.9.5100-5"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mastorakos G, Chrousos GP, Weber JS. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 77: 1690-1694, 1993.","DOI":"10.1210\/jc.77.6.1690"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Sarwar N, Butterworth AS, Freitag DF, et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 379: 1205-1213, 2012.","DOI":"10.1016\/S0140-6736(11)61931-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Takimoto K, Levitan ES. Glucocorticoid induction of Kv1.5 K<sup>+<\/sup> channel gene expression in ventricle of rat heart. Circ Res 75: 1006-1013, 1994.","DOI":"10.1161\/01.RES.75.6.1006"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Narayanan N. Effects of adrenalectomy and in vivo administration of dexamethasone on ATP-dependent calcium accumulation by sarcoplasmic reticulum from rat heart. J Mol Cell Cardiol 15: 7-15, 1983.","DOI":"10.1016\/0022-2828(83)90303-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tokudome S, Sano M, Shinmura K, et al. Glucocorticoid protects rodent hearts from ischemia\/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. J Clin Invest 119: 1477-1488, 2009.","DOI":"10.1172\/JCI37413"},{"key":"16","unstructured":"16. Tamada D, Onodera T, Kitamura T, et al. Hyperthyroidism due to thyroid-stimulating hormone secretion after surgery for Cushing&apos;s syndrome: a novel cause of the syndrome of inappropriate secretion of thyroid-stimulating hormone. J Clin Endocrinol Metab 98: 2656-2662, 2013."},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Klein I, Danzi S. Thyroid disease and the heart. Circulation 116: 1725-1735, 2007.","DOI":"10.1161\/CIRCULATIONAHA.106.678326"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Group JJW. Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013). Circ J 78: 2779-2801, 2014.","DOI":"10.1253\/circj.CJ-66-0098"},{"key":"19","unstructured":"19. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34: 2949-3003, 2013."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Takagi S, Goto Y, Hirose E, et al. Successful treatment of refractory vasospastic angina with corticosteroids: coronary arterial hyperactivity caused by local inflammation? Circ J 68: 17-22, 2004.","DOI":"10.1253\/circj.68.17"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nomura T, Keira N, Taminishi S, et al. Corticosteroid therapy was effective in controlling refractory coronary vasospasms complicated by hypereosinophilia. Intern Med 53: 735-738, 2014.","DOI":"10.2169\/internalmedicine.53.1639"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Takano T, Ozaki K, Tanaka K, Yanagawa T, Ozawa T, Minamino T. Efficacy of corticosteroid treatment for refractory multivessel vasospastic coronary angina with hypereosinophilia. Intern Med 57: 3111-3115, 2018.","DOI":"10.2169\/internalmedicine.0886-18"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med 63: 200-207, 1977.","DOI":"10.1016\/0002-9343(77)90253-4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/15\/59_4337-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T03:35:13Z","timestamp":1596252913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/15\/59_4337-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":23,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4337-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]}}}